GlassScriptPhysician profile
Erin K Warning
NPI 1447772983
$7,299.67
in general payments reported to CMS, 2019-2025
36 companies · $1,024 in 2025
The $1,024 reported for 2025 was more than what 81% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,690 · 2022: $1,506 · 2023: $1,145 · 2024: $935 · 2025: $1,024.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,103.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,115.82 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $955.89 | 2021-2025 | Breztri, Airsupra, Farxiga |
| Novo Nordisk INC | $793.25 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $738.41 | 2021-2022 | |
| Abbvie INC. | $527.71 | 2021-2025 | |
| Glaxosmithkline, LLC. | $363.00 | 2021-2025 | Shingrix, Trelegy Ellipta |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $361.48 | 2021-2025 | Xifaxan |
| Pfizer INC. | $263.26 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $239.35 | 2021-2023 | |
| Astellas Pharma US INC | $236.26 | 2021-2025 | Veozah |
| Exact Sciences Corporation | $224.19 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Nestle Healthcare Nutrition INC. | $198.51 | 2021-2022 | |
| Phathom Pharmaceuticals, INC. | $150.75 | 2024-2025 | Voquezna |
| Janssen Pharmaceuticals, INC | $144.21 | 2021-2022 | |
| Edwards Lifesciences Corporation | $114.83 | 2022-2025 | Sapien 3 Ultra Resilia |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Warning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.